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Abstract
Food reinforcement, or the motivation to eat, has been associated with increased energy intake,
greater body weight and prospective weight gain. Much of the previous research on the reinforcing
value of food has focused on the role of dopamine, but it may be worthwhile to examine genetic
polymorphisms in the serotonin and opioid systems as these neurotransmitters have been shown to
be related to reinforcement processes and to influence energy intake. We examined the
relationship among 44 candidate genetic polymorphisms in the dopamine, serotonin and opioid
systems, and food reinforcement and body mass index (BMI) in a sample of 245 individuals.
Polymorphisms in the Monoamine oxidase A (MAOA-LPR) and serotonin receptor 2A genes
(rs6314) moderated the effect of food reinforcement on BMI, accounting for an additional 5-10%
variance and revealed a potential role of the single nucleotide polymorphism, rs6314 in the
serotonin 2A receptor as a differential susceptibility factor for obesity. Differential susceptibility
describes a factor that can confer either risk or protection depending on a second variable, such
that rs6314 is predictive of both high and low BMI based on the level of food reinforcement,
while the diathesis stress or dual-gain model influences only one end of the outcome measure. The
interaction with MAOA-LPR better fit the dual-risk or diathesis stress model, with the 3.5R/4R
allele conferring protection for individuals low in food reinforcement. These results provide new
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insight into genes theoretically involved in obesity and support the hypothesis that genetics
moderate the association between food reinforcement on BMI.
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Differential susceptibility of a functional polymorphism in the serotonin 2A
receptor moderates the relationship between food reinforcement and Body
mass index
Food reinforcement is a measure of the motivation to eat, or the effort one is willing to
expend to obtain a desired food on a progressive ratio schedule (Epstein, Leddy, Temple, &
Faith, 2007). Both obese children (Temple, Legierski, Giacomelli, Salvy, & Epstein, 2008)
and adults (Giesen, Havermans, Douven, Tekelenburg, & Jansen, 2010; Saelens & Epstein,
1996) demonstrate increased food reinforcement compared to their leaner peers. High food
reinforcement predicts increased weight gain in children (Hill, Saxton, Webber, Blundell, &
Wardle, 2009) and sensitization of food reinforcement, or the increase in motivation to eat
after prolonged exposure to specific high energy-dense foods, predicts weight gain in adults
(Temple & Epstein, 2011). Research has shown that several behavioral phenotypes,
including dietary restraint and disinhibition (Epstein, Lin, Carr, & Fletcher, 2012) and
impulsivity (Appelhans et al., 2011; Rollins, Dearing, & Epstein, 2010) moderate the
influence of food reinforcement on BMI or energy intake.
Genetic factors may also interact with food reinforcement to predict BMI. Dopamine is a
key neurotransmitter associated with motivated behaviors involving both food and drug
reinforcement and is found in brain regions associated with reward such as the ventral
tegmental area and amygdala (Volkow, Fowler, Wang, Swanson, & Telang, 2007; Volkow,
Wang, & Baler, 2011). Appetitive stimuli, including primary reinforcers such as food,
increase dopamine release in brain reward centers (Cheng, De Bruin, & Feenstra, 2003) and
it is thought that increases in dopamine release are directly related to motivation and
reinforcement or the currency that determines a reinforcers' motivational value (Salamone &
Correa, 2002). Polymorphisms in the dopamine D2 receptor (DRD2), including the ANKK1
or Taq1A allele, that lead to a reduction in D2 receptor protein levels, are associated with
obesity (Spitz et al., 2000; Thomas, Critchley, Tomlinson, Cockram, & Chan, 2001),
increased energy intake (Epstein, Temple, et al., 2007; Epstein et al., 2004) and high food
reinforcement (Epstein, Temple, et al., 2007), in addition to associations with alcoholism,
nicotine and opioid dependence (Noble, 2000). Research has implicated dopaminergic genes
and receptor regulation in the risk of developing obesity as an adolescent, such that
polymorphisms in the dopamine D2 or D4 receptors predicted weight gain in youth with
weak striatal activation to food cues (Stice, Yokum, Bohon, Marti, & Smolen, 2010).
However, unlike drugs of abuse, obesity and energy intake involve several additional neural
systems involving hunger and satiety.
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Other neurotransmitter systems that may interact with food reinforcement include the opioid
and serotonin systems. Opioids have been shown to increase operant responding and
breakpoint for food in animals (Peciña & Smith, 2010; Solinas & Goldberg, 2005). Opioid
agonists increase operant responding, which is blocked by antagonists including naloxone
(Solinas & Goldberg, 2005). Deficiencies in opioid receptors or neuropeptides decrease
operant responding in animals (Peciña & Smith, 2010), suggesting a contribution of opioid
neuropeptides to motivational processes. Research examining the influence of serotonin on
motivation, however, has had mixed results. Animal models have shown that serotonin
receptor agonists decrease operant responding for food (De Vry, Schreiber, Daschke, &
Jentzsch, 2003), while chronic administration of selective serotonin reuptake inhibitors
(SSRIs) increased responding for cocaine in rats (Sasaki-Adams & Kelley, 2001). One study
showed reduced operant responding for cocaine in serotonin transporter knock-out mice
(Sanders, Hussain, Hen, & Zhuang, 2007), but two other studies showed no changes in
cocaine reinforcement (Thomsen, Hall, Uhl, & Caine, 2009) or effort to obtain food (Denk
et al., 2005).
It is possible that these neurotransmitter systems interact with behavioral phenotypes to
predict complex outcomes, including obesity. One influential theory of gene-environment
interactions is the diathesis stress or dual-risk model, in which individuals with specific risk
factors are disproportionately influenced by negative environmental factors, such as stress
(Belsky & Pluess, 2009). Many studies examine only the negative aspects of the
environment and new research has suggested that more informative relationships may be
found when examining a wide range of positive and negative environmental factors (Belsky
& Pluess, 2009). Another way to conceptualize gene-environment interactions include the
dual-gain model, which suggests gene-environment interactions can be protective, rather
than increase risk. Factors that confer plasticity, or an increase in sensitivity to the
environment, show increased positive outcomes in supportive environments and more
negative outcomes in stressful environments (Belsky, Bakermans-Kranenburg, & Van
Ijzendoorn, 2007). This effect is termed differential susceptibility and re-examination of
previous studies of diathesis-stress have identified that both genetic and behavioral factors
fit the differential susceptibility model (Belsky & Pluess, 2009). For example, research has
found the short allele of the 5-HTTLPR polymorphism in the serotonin transporter gene is
associated with increased depression, anxiety and attention deficit hyperactivity disorder in a
variety of stressful environments, including stressful life events, low socioeconomic status
and childhood emotional abuse, but a lower propensity to exhibit these issues in supportive
environments (Belsky & Pluess, 2009). Similarly, investigators have shown that the DRD4
7R allele confers risk for impulsivity, as measured by delay discounting, in children of low
socio-economic status, but is a protective factor for less impulsive choice in children living
in a non-disadvantaged environment (Sweitzer et al., 2012), providing evidence of
differential susceptibility. This study aimed to examine the interactions between food
reinforcement and genetic polymorphisms in the dopamine, opioid and serotonin systems on
BMI, controlling for population stratification and reinforcing value of an alternative
reinforcer.
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A sample of 245 (119 males, 126 females) participants with a broad range of BMI
(18.5-58.6) (134 non-obese, 111 obese) and twenty seven percent minority, were examined
for single marker genetic associations. BMI can be categorized as obese, or BMI> 30 and
non-obese BMI< 30 and our sample included 134 non-obese and 111 obese individuals.
Participants were recruited from an existing family database, newspaper ads, flyers posted
around the University at Buffalo campuses and in community settings, web based
recruitment (e.g. ads on Craig's list and on the department's website) and direct mailings
targeted to community residents between the ages of 18-50. Participants were excluded from
the study if they were taking medications associated with loss of appetite, were smokers, had
diabetes, had previously been diagnosed with an eating disorder or psychiatric disorder (e.g.
anxiety, depression, attention deficit hyperactivity disorder), were allergic to the ingredients
in the study foods, were currently dieting, and did not rate at least a moderate liking (≥4 on a
9 point Likert type scale) for five out of the six study foods. Participants received a $50 gift
certificate to local stores for completing the study. The study was approved by the
University at Buffalo Health Sciences Institutional Review Board. Participant characteristics
by sex and obesity status are shown in Table 1.
Procedures
Participants visited the laboratory for two sessions, an ad libitum snack-eating session, and
the food reinforcement session. Both experimental sessions were scheduled between the
hours of 2PM and 5PM, during a normal period that individuals would consume additional
calories outside of meal time. Participants were asked to refrain from eating or drinking,
with the exception of water, for at least 3 hours prior to the test session and to refrain from
consuming the experimental foods in the 24 hours prior to the test session. Upon initial
arrival to the laboratory, participants read and signed consent forms, completed a same day
and 24 hour food recall, hunger questionnaires and were asked to provide a saliva DNA
sample. Participants were asked to rinse their mouth with water and then spit into a plastic
vial. Participants who had difficulty providing 2mL of saliva were asked to place a small
dab of sugar on the center of their tongue to increase saliva production. Prior to the start of
each session participants were provided with a preload of a Luna Sunrise Blueberry Bliss,
Strawberry Crumble or Vanilla Almond Breakfast bar (Clif Bar & Company; Berkeley, CA,
42g, 150kcal, 4g fat, 23g carbohydrates, 7g protein) to minimize the effects of hunger on
energy intake and food reinforcement. The inclusion of a standard preload increases the
ability to show individual differences in food reinforcement (Reiss & Havercamp, 1996).
Demographic information, height and weight measurements and three dietary habits
questionnaires were administered during the ad libitum eating session. Results relevant to
the ad libitum eating task have been presented (Epstein, Carr, Lin, & Fletcher, 2011), and
are not reported here.
Measurement
Demographics—Participant education level and income were assessed using a
standardized questionnaire.
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Height and weight—The participant's weight and height were measured using a digital
scale (TANITA Corporation of America Inc, Arlington Heights, IL) and a digital
stadiometer (Measurement Concepts & Quick Medical, North Bend, WA). On the basis of
height and weight data, body mass index (BMI) was calculated according to the following
formula: BMI=kg/m2. Individuals were considered obese if their BMI was at least 30kg/m2
and non-obese if their BMI was less than 30kg/m2 (NHLBI Obesity Education Initiative
Expert Panel, 1998).
Eating Questionnaires—Participants completed the Three Factor Eating Questionnaire
(TFEQ) (Stunkard & Messick, 1985), the Questionnaire of Eating and Weight Patterns
(QEWP) (Spitzer et al., 1992), and the Binge Eating Scale (BES) (Gormally, Black, Daston,
& Rardin, 1982). The TFEQ is a validated instrument to detect dietary restraint (Allison,
Kalinsky, & Gorman, 1992; Laessle, Tuschl, Kotthaus, & Pirke, 1989) with three subscales
that assess dietary restraint, hunger and disinhibition. The QEWP and BES are used to
assess binge eating disorder. Participants were identified as potentially having binge eating
disorder if they scored higher than 27 on the BES or were indicated as having the disorder
by the QEWP. Any participant identified as potentially having binge eating disorder was
required to complete the Eating Disorders Examination (Bryant-Waugh, Cooper, Taylor, &
Lask, 1996), administered by a trained personnel in an additional session. No participants in
this sample met the criteria for binge eating disorder.
Food liking, hunger—Subjective ratings of hunger were collected pre and post intake of
the pre-load and after both test sessions using a 10-point Likert-type scale. Food hedonics
were also measured pre and post intake of the preload and after the session for the food
reinforcement session. For hunger and fullness, 1 indicated not at all hungry or not at all full
and 10 indicated extremely hungry or extremely full, while for hedonics 1 indicated not
liking at all and 9 indicated liking very much.
Food reinforcement task—The reinforcing value of food was measured by determining
the number of responses participants made for food or food alternatives on progressive ratio
schedules of reinforcement. The experimental environment included two computer stations
that participants could go back and forth between. At one station, participants could earn
points toward food and at the other station they could earn points for time to spend reading
Time and Newsweek magazines. This alternative activity was provided to reduce the
likelihood that participants would engage in responding out of boredom. Participants were
instructed on how to use the computer task and given a practice session. Following the
instructions for the task, the experimenter left the room. An intercom and closed circuit
video system were present in the room so the experimenter could observe the participant and
the participant could communicate with the experimenter.
The reinforcement task is similar to a slot machine with shapes that rotate on the screen and
a point is earned each time the three shapes match in shape and color. For every five points
earned, the subject was able to receive a 70-101 kcal (14 - 20 g) portion of his or her
preferred snack food selected during the ad libitum eating session or 2 minutes of time to
spend reading depending on which reward they were working for. The programmed
reinforcement schedules for food and reading were progressive fixed ratio schedules with
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response requirements of 4,8, 16, 32, 64, 128, 256, 512, 1,024, 2,048 and so forth for each
point. Participants were instructed to perform one activity at a time (i.e. play the computer
game, eat or read), and that the session would end when they no longer wished to earn points
for access to food or time to spend reading. The food chosen for the task was the most
preferred food from a list of six palatable, high-energy density snack foods (amount of food
presented (g) and energy density (kcal/g) shown in parentheses): Wavy Lay's Potato Chips
(57 g, 5.4); Cooler Ranch Doritos (56 g, 5.4); M's (60 g, 5.0);Twix (48 g, 5.0); Kit Kat (42 g,
5.0); and Butterfinger (57g, 4.5). Water was provided ad libitum.
The food reinforcement task generates an overall response curve showing responding for
food across the levels of reinforcement. The task also generates a total number of responses
made for a reinforcer across all levels of reinforcement and was used to generate a
breakpoint for responding, or PMAX, which was defined as the last reinforcement schedule
(i.e. 4, 8, 16, 32, 64, 128, 256, 512, 1024, 2048) completed for access to the food
(PMAX FOOD) or non food alternative (PMAXREADING).
Genotyping
DNA was collected from saliva samples collected in a plastic vial (Oragene, DNA Genotek
Inc, Ottawa, Canada) and extracted using a commercially available genomic DNA quick
preparation kit (Gentra Systems, Minneapolis, MN). DNA was extracted from the samples
yielding 20µL of DNA at a concentration of 100-130ng/µL. After DNA purification, each
sample was stored at -20°C for later analysis.
Gene and Single Nucleotide Polymorphism Selection—Candidate genes were
chosen to represent polymorphisms of the dopamine, opioid and serotonin systems that have
been associated with BMI, adiposity, food reinforcement, reward mechanisms or
impulsivity. All types of gene products were considered including receptors, transporters
and metabolic enzymes. Genes examined in the dopamine system include all 5 receptors
(dopamine receptors DRD1, DRD2, DR D3, DRD4 and DRD5), tyrosine hydroxylase (TH),
catecholamine O-methyltransferase (COMT) and monoamine oxidase-A (MAOA), the
dopamine transporter (DAT1), dopamine beta-hydroxylase (DBH), dopa decarboxylase
(aromatic L-amino acid decarboxylase) (DDC) and Sepiapterin reductase (SPR). Genes
chosen in the serotonin system included receptors (5HT1A, 5HT1B, 5HT2A), and serotonin
transporter (SERT) and Tryptophan hydroxylase 2 (TPH2). Mutations in the opioid delta
receptor (OPRD) were also genotyped. Once candidate genes were established, single
nucleotide polymorphisms (SNP) were chosen based on their previous associations with
obesity, reward, impulsivity or drug abuse, or known effects on gene transcription or protein
function. 161 SNPs were genotyped on an Illumina Golden gate platform (Illumina, San
Diego, CA).
Dopamine Receptor D1 (DRD1)—The Ddel (A48G) polymorphism (rs4532) in the
DRD1 gene is found on the 5′ untranslated region of exon 2 at base pair (bp) 48. The
primers used were described by Limosin (Limosin, Loze, Rouillon, Adès & Gorwood, 2003)
and were modified to sense 5′- ACT GAC CCC TAT TCC CTG CT-3′ and antisense 5′-
AGC ACA GAC CAG CGT GTT C-3′ and amplified a 207 bp fragment. The restriction
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endonuclease Ddel digests the 207 bp fragment which was separated on a 10%
polyacrylamide gel by electrophoresis. The polymorphism A48G creates two restriction sites
for the A allele, forming three fragments of 146bp, 42bp and 19bp, while the G allele
includes only one restriction site forming two fragments of 146bp and 61bp in size. The
DRD1 gene was coded AA, AG and GG, (or A1/A1, A1/A2, A2/A2).
Dopamine Receptor D2 (DRD2)—For detection of the Taq1A polymorphism
(rs1800497) in the ANKK1 gene, which is in linkage disequilibrium with DRD2 gene, a
region of 304 base pairs (bp) was amplified. The primers first described by Grandy et. al
(Grandy et al., 1989) were modified to sense 5′ –CCC TTC CTG AGT GTC ATC A-3′ and
antisense 5′-CGG CTG GCC AAG TTG TCT-3′. The restriction endonuclease Taq1 digests
the 304-bp amplicon, and subsequently the fragments are separated on a 6% polyacrylimide
gel by electrophoresis. The Taq1A polymorphism in the DRD2 gene at Position 32806 T to
C creates a restriction site resulting in partition of the 304 bp fragment of 177 and 127 bp.
The A1/A1 or TT variant therefore is represented by an uncut amplicon of 304bp; the A1/A2
or TC heterozygous form digests in three fragments of 304, 177 and 127 bp; and the A2/A2
or CC variant is characterized by two fragments of 177 and 127 bp. The DRD2 was coded
for the allele patterns of A2/A2, A2/A1, and A1/A1.
Dopamine Receptor D3 (DRD3)—The DRD3 gene includes a mutation (rs6280) of an A
to G substitution resulting in a serine to glycine amino acid change. Primers were modified
from Messas (Messas et al., 2005) and including the sense 5′-GCT CTA TCT CCA ACT
CTC ACA-3′ and antisense 5′-AAG TCT ACT CAC CCT CCA GGT TA-3′ which
amplified a 362bp fragment. The restriction enzyme Msc1 cuts the fragment results in one
fragment of 304bp for the A1 or G allele and two fragments of 206bp and 98bp for A2 or the
A allele. Restriction fragments were analyzed on a 10% polyacrylamide gel. The DRD3
polymorphism was coded A1/A1, A1/A2 and A2/A2, or GG, AG, AA.
Dopamine Receptor D4 (DRD4)—The polymorphism (rs4646984) examined in the
dopamine receptor DRD4 gene included a 48 bp variable tandem repeat in exon 3. Methods
are previously described by Kustanovich et al (Kustanovich et al., 2004) and the modified
primers included the sense 5′-CTA CCC TGC CCG CTC ATG-3′ and antisense 5′-CCG
GTG ATC TTG GCA CGC-3′. Briefly, PCR was used to amplify the region of interest and
were analyzed after electrophoresis by comparing with molecular weight standards. The
DRD4 was coded as absence of the 7R allele (non-7R/non-7R), presence of at least one 7R
allele (7R/non-7R) and presence of two copies of the 7R allele (7R/7R). The dopamine D4
receptor included 2-9 tandem repeats with the two most common alleles being 4R (65%) and
7R (18%) and did not differ from reported allele frequencies (Vandenbergh et al., 2007).
Dopamine Receptor D5 (DRD5)—The dopamine receptor DRD5 contains a di-
nucleotide (CT)n repeat 18.5 kb upstream of the gene. Methods have been previously
described by Manor (Manor et al., 2004) and the modified primers included the sense 5′-
CGT GTA TGA TCC CTG CAG-3′ and antisense 5′-GCT CAT GAG AAG AAT GGA
GTG-3′. Briefly PCR products were amplified in a multiplex reaction and electrophoresed.
The dopamine D5 receptor included 2-13 repeats with 9R (148 bp) being the most common
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allele in our data (41%) and 10R and 8R accounting for 13% of our sample each. Allele
frequencies in our sample had similar frequencies to previous reports (Squassina et al.,
2008). The DRD5 polymorphism was coded as absence of the 9R allele, presence of at least
one 9R and presence of two 9R alleles.
Catecholamine-O-methyltransferase—The COMT gene examined results in a
Val158Met, or G to A, substitution (rs4680) amplified using the primers described by
(Yacubian et al., 2007) 5′-ACC CAG CGG ATG GTG GAT TTC-3′ 5′-GCC CTT TTT
CCA GGT CTG AC-3′. The resulting product was digested using restriction enzyme N1alll
and analyzed on a 10% polyacrylamide gel by electrophoresis. The COMT polymorphism
was coded for patterns of GG, GA, and AA.
Monoamine Oxidase A (MAOA)—MAOA-LPR was amplified using the following
primers as described by (Wiesbeck et al., 2006); sense 5′-CCC AGG CTG CTC CAG AAA
C-3′ and antisense 5′-GGA CCT GGG CAG TTG TGC-3′. Digestion by Taq polymerase
resulted in three possible fragments of varying copies of a 30-bp repeat, corresponding to the
three alleles; 3 repeat (209bp), 4 repeat (239bp), 5 repeat (269bp). Our results included both
a 2 repeat allele and a 3.5 repeat allele (227bp), distinguishable from the other more
common alleles. Results were analyzed by electrophoresis on a 6% acrylamide gel. MAOA-
LPR was coded for in the presence of two 3.5R or 4R alleles (indicating high activity of the
enzyme, (Sabol, Hu, & Hamer, 1998), presence of one 3.5R or 4R and absence of any 3.5R
or 4R alleles. The 4R (61%) and 3R (35%) occurred the most frequently in our sample and
did not differ from previously reported frequencies (Sabol et al., 1998). The MAOA gene is
located on the X chromosome, so analyses for this gene were stratified by sex.
Tyrosine Hydroxylase (TH)—Tyrosine hydroxylase contains a 4 bp (TCAT)n repeat
(rs71029110). Methods have been previously described by Zhang et al (Zhang et al., 2004),
however, briefly, sense 5′-GGT GTT TGA GTC CCT GTT GG-3′ and antisense 5′-GTA
CAC AGG GCT TCC GAG TG-3′ primers were modified to amplify a 498 bp section.
Exonuclease I and shrimp alkaline phosphatase were used to remove primers and dNTPs,
before cycle sequencing with BigDye terminators. Sequenced alleles included between 6-10
TCAT repeats and the 9.3 repeat allele in which the 9 repeat allele includes an extra TCA
repeat. The 9.3 allele was the most common (30%) which did not differ from previous
reports (Wei, Ramchand, & Hemmings, 1997). Tyrosine hydroxylase, rs71029110, was
coded for the absence of a 9.3R or 10R allele, presence of at least one 9.3R or 10R allele and
presence of two 9.3R or 10R alleles.
Dopamine Transporter (DAT1)—Analysis of DAT1 gene focused on the VNTR of a
40bp sequence (rs28363170), which recurs 3 to 11 times. Primers first described by
Vandenbergh et al. (Vandenbergh et al., 1992) were modified to sense 5′- GGT GTA GGG
AAC GGC CTG AG-3′ and antisense 5′-CTG GAG GTC ACG GCT CAA GG-3′. The
amplicon was analyzed on a 10% polyacrylamide gel by electrophoresis. The large
increment of 40bp provides distinct typing of the VNTRs. The DAT1 included the 6R allele
and 8-12 repeat alleles with the 10R (77%) and 9R (21%) being the most frequent (Kang,
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Palmatier & Kidd, 1999). The DAT1 genotype was coded for the allele patterns of non 10R
(e.g. 9R/9R, 9R/11R), at least one 10R (e.g. 10R/any) and 10R/10R patterns.
Ancestry Informative markers—To control for individual ancestry (Halder, Shriver,
Thomas, Fernandez, & Frudakis, 2008; Hoggart et al., 2003; Rosenberg et al., 2002), we
genotyped a panel of 110 SNPs to estimate each individual's proportion of European, Asian
and African ancestry (Kosoy et al., 2009). Proportions were estimated using the Bayesian
clustering algorithms implemented in the program STRUCTURE v2 (Pritchard, Stephens, &
Donnelly, 2000). Proportion of African ancestry was then used as a covariate in all
regression analyses.
Analytic Plan
Participant characteristics were examined by sex and food reinforcement (mean breakpoint
split of 62.5) using analysis of variance for continuous variables and chi-square for
categorical variables to identify potential covariates.
The genetic dataset was cleaned by removing participants who were not successfully
genotyped for at least 90% of the SNPs. SNPs were removed on the basis of a minor allele
frequency (MAF) <0.05 and Hardy-Weinberg equilibrium <0.001. Due to the diversity of
our sample, both minor allele frequency and Hardy-Weinberg equilibrium were examined
for differences between racial populations, split into Caucasian, African and other based on
self-identified ethnicity. For Hardy-Weinberg equilibrium, SNPs were excluded if they
violated the criteria in any population as this may be indicative of a SNP that can
differentiate between populations.
Genes with multiple allelic variations were examined for call rates, but not traditional
measures of Hardy-Weinberg equilibrium. As variable tandem repeat genotypes can include
many more than two alleles, cell frequencies for the less frequent alleles can be less than 5,
which is inappropriate for analyzing Hardy-Weinberg equilibrium using the traditional Chi
square analyses. Allele frequencies for the multi-allelic genes were examined for similarity
to previously observed frequencies as reported in the methods section. For the SNPs, an
additive genetic model was used, coded for the number of minor alleles, 0, 1 or 2. All
subsequent genetic analyses were performed using PLINK (Purcell et al., 2007).
Regression analyses were conducted to determine if individual polymorphisms were
associated with PMAXFOOD or BMI, while controlling for variables that differed by sex,
including dietary restraint, or variables that differed by food reinforcement, including sex,
income, dietary hunger and PMAXREADING and co-varying proportion African ancestry.
Additional regression models were analyzed examining the potential interaction between
PMAXFOOD and genes on BMI. P values, including those for the interaction terms, were
corrected using False Discovery (FDR) estimates (Benjamini & Hochberg, 1995) for the 44
candidate polymorphisms studied. FDR is a multiple testing procedure that probabilistically
controls for the proportion of false positive results in a set of results declared significant.
Tests are rank-ordered based on the ascending p-value of interest and a significance cutoff is
calculated by dividing the rank order by the total number of tests and multiplying by the
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desired FDR value (e.g. 0.05). FDR control methods of this type are somewhat more
powerful than are traditional family-wide error control methods (Gadbury et al., 2008),
which seemed desirable as false negatives are as important to avoid as false positives. An
Incremental F test was used to determine if the interaction significantly increased the
variance accounted for by the model (Wampold & Freund, 1987). Simple slopes analyses
were conducted to determine the moderating association of the additive model on high
PMAXFOOD (+1 Standard Deviation) and low PMAXFOOD (-1 Standard Deviation). To
assess genes as potential differential susceptibility factors, the steps outlined by Belsky
(Belsky et al., 2007) were followed. In brief, a true (cross-over) interaction was determined
by plotting the predicted graph, and simple slopes were used to assess the relation between
PMAXFOOD and BMI at each genotype. The non-risk allele should show no relation
between BMI and PMAXFOOD, while the risk allele should show a strong relation that
covers both the high and low range of BMI.
Separate exploratory analyses were conducted to examine the moderating effect of dietary
restraint, hunger, disinhibition, minority status and income on the relationship between
genes, food reinforcement and BMI. Three-way interactions were examined and, for the
exploratory analysis, each model was only corrected for the number of genes, rather than
both the number of genes and number of additional models. Any interaction that passed
correction was examined using simple slopes.
Results
Participants
The average participant was 34.5 ± 10.6 (mean ± standard deviation) years of age with a
BMI of 30.1 ± 7.6 (see Table 1). There were significant differences between males and
females on dietary restraint and PMAXFOOD, with females reporting higher restrained eating
and males having higher food reinforcement. There were significant differences in reading
reinforcement, dietary restraint and hunger between the high and low food reinforcement
groups, which were included as covariates in subsequent models. Chi-square analysis did
not reveal any sex differences in education, income or race, but there were differences by
food reinforcement group for income, so this was also included as a covariate in testing
predictors of BMI. Significant differences in percentage minorities were observed between
high and low food reinforcement groups, and proportion of African ancestry was included as
a covariate to control for population stratification.
Genotyping
A total of 54 candidate polymorphisms were genotyped for analysis. The final dataset
included only 44; 10 were removed based on minor allele frequency<0.05, and there were
no violations of Hardy-Weinberg equilibrium (<0.001) (Table 2). For the non-SNP genes,
minor allele frequencies and Hardy-Weinberg equilibrium are based on the coding schemes
posited in the methods section.
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No individual genetic polymorphisms were significantly associated with BMI or
PMAXFOOD after FDR correction. Thirty-nine genes showed non-significant results before
correction for BMI and 43 genes showing non-significant results before correction for
PMAXFOOD. After controlling for sex, income, dietary restraint and hunger,
PMAXREADING and proportion African ancestry, two polymorphisms interacted with
PMAXFOOD to predict BMI; rs6314 (B = 0.03, p = 0.0003, FDR = 0.01) and MAOA-LPR (B
= 0.02, p = 0.0005, FDR = 0.02) and 29 were non-significant before correction. Both
interactions significantly improved the fit of the model; rs6314 (FINC(1,235) = 12.2, p =
0.0006, FDR = 0.02) and MAOA-LPR (FINC(1,237) = 12.1, p = 0.0005, FDR = 0.03).
The rs6314 gene was re-coded for a dominant allele effect, as there was less than 5% of the
sample with an AA genotype. The interaction between rs6314 and PMAXFOOD accounted
for an additional 5.5% of the variance in BMI. For rs6314, there was a significant
association between genotype and BMI at both high (B = 3.63, p = 0.03) and low (B = -5.06,
p = 0.004) PMAXFOOD (See Figure 1). The presence of the minor allele A predicted a BMI
of 33.1 kg/m2 for subjects with high PMAXFOOD and a BMI of 24.5 kg/m2 for subjects with
low PMAXFOOD (Figure 1). There is also a significant association between PMAXFOOD and
BMI for individuals with the AA or GA genotype (B = 0.03, p = 0.0001) but not the GG
genotype (B = -0.003, p = 0.59). Presence of the A allele predicted the highest BMI when
individuals were also high in food reinforcement and the lowest BMI when individuals were
low in food reinforcement, while food reinforcement did not predict BMI for those with the
GG genotype. These results indicate that the A allele is associated with both the highest and
lowest BMI, suggesting that rs6314 may confer differential susceptibility towards food
reinforcement, while the alternate genotype, GG, does not influence BMI as a function of
food reinforcement.
Analyses for MAOA-LPR were stratified by sex as this gene is located on the X
chromosome. Males were coded for presence or absence of the risk alleles (3.5R and 4R)
and females coded for the full additive model. There was a significant interaction with
PMAXFOOD in males (B = 0.03, p = 0.0005, FDR = 0.02, n =119)(See Figure 2) which
accounted for an additional 10.0% of the variance in BMI, but this interaction was not
significant in females (B = 0.002, p = 0.92, n = 125). Simple slopes analysis for MAOA-LPR
in males revealed a significant association between food reinforcement and BMI for
individuals with a copy of the 3.5R or 4R high activity allele (B = 0.03, p = 0.0003), such
that individuals with high PMAXFOOD had a BMI of 35.1 kg/m2 compared to a BMI of 26.8
kg/m2 for individuals with low PMAXFOOD, but no relationship for individuals with the low
activity allele (B = -0.01, p = 0.30) (Figure 2). In addition there was a significant effect of
genotype for individuals with low PMAXFOOD (B = -5.18 p = 0.01), but not high
PMAXFOOD (B = 3.45, p = 0.05). These results are consistent with 3.5R/4R as a protective
factor for individuals with low food reinforcement and fit a dual-risk model, in which
genotype influences the outcome measure disproportionately in one environment, but not
another.
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For the exploratory analysis, a median split of dietary hunger (<5.4, ≥5.3) revealed
significant differences between the groups in age (F(1,243) = 5.05, p = 0.03) and was
included as an additional covariate. There were significant three way interactions between
genetics, PMAXFOOD and dietary hunger found with two SNPs; rs2066713 (B = -0.007, p =
0.0007, FDR = 0.03) located in the serotonin transporter SLC6A gene (Figure 3), and
rs7997012 (B = 0.007, p = 0.0008, FDR = 0.03) located in the HTR2A gene (Figure 3). The
three-way interaction with rs2066713 accounted for an additional 4.4 percent variance
above the two-way interaction model (FINC(1, 230) = 11.9, p = 0.0006). The simple slopes for
rs2066713 revealed a main effect of genotype at the combination of low hunger (-1 standard
deviation; SD) and high food reinforcement (+1 SD) (B = 6.92, p = 0.003) and the
combination of high hunger (+1 SD) and low food reinforcement (-1 SD) (B = 3.56, p =
0.005). In both cases, increasing number of copies of the A allele was associated with a
dose-dependent increase in BMI. For individuals with low hunger and high food
reinforcement there was an increase in BMI from 27.3 kg/m2 (GG) to 41.0 kg/m2 (AA) with
increasing copies of the risk allele (Figure 3A). Individuals with a combination of high
hunger and low food reinforcement showed similar results with increasing copies of the A
risk allele was associated with increased BMI; GG (27.4 kg/m2), AG (31.5 kg/m2) and AA
(35.6 kg/m2) (Figure 3B). The three way interaction with rs7997012 accounted for an
additional 4.4 percent variance above the two-way interaction model (FINC(1, 231) = 11.70, p
= 0.0007). For rs7997012, there was only a significant effect of genotype in individuals who
were both low hunger (-1 SD) and low food reinforcement (-1 SD) (B = 5.34, p = 0.001)
with increasing copies of the G allele associated with an increase in BMI; AA (25.7 kg/m2),
AG (31.43 kg/m2) and AA (37.1 kg/m2) (Figure 3C).
Discussion
Differential susceptibility describes the effect of some genetic or personality factors that
confer greater responsivity to the environment such that individuals with these factors
exhibit both the high and low points of the outcome measure (Belsky et al., 2007; Belsky &
Pluess, 2009). The interaction between food reinforcement and rs6314, a single nucleotide
polymorphism in the HTR2A gene, shows evidence of differential susceptibility, such that
the “risk allele” seems to confer both increased and decreased risk of high BMI, at high and
low food reinforcement, respectively. In our sample, individuals with the rs6314 risk allele
had both the highest and lowest BMI's. The A allele may be associated with a blunted
response to serotonin stimulation, perhaps related to decreased sensitivity to feelings of
satiety. In combination with a high motivation to eat, this mutation is associated with
increased BMI. However, a blunted response to serotonin and low food reinforcement is
associated with significantly lower BMIs, which may suggest that this population's
decreased obesity may be related to a different mechanism than rs6314's effects on satiety.
An examination of the interaction effect of MAOA-LPR suggests a dual-gain model, with
protective effects of the genotype at low food reinforcement. The high activity MAOA-LPR
risk allele is associated with decreases in brain serotonin, as MAOA is an enzyme involved
in neurotransmitter breakdown. It is possible the decreased serotonin availability is
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potentially related to decreased feelings of satiety. MAOA-LPR risk allele also reduces
synaptic dopamine availability, with theories of both hyper and hypo-functionality being
associated with obesity (Stice, Spoor, Bohon, & Small, 2008; Stice, Yokum, Burger,
Epstein, & Small, 2011). In our data, a combination of low food reinforcement and low
synaptic dopamine levels is associated with lower BMIs than individuals with normal
synaptic dopamine. The high activity allele for MAOA-LPR has also shown associations
with both novelty seeking and reward dependence in humans (Shiraishi et al., 2006), in
addition to a general influence of serotonin on impulsivity, including choices of delayed
rewards (Bizot, Le Bihan, Puech, Hamon, & Thiebot, 1999; Schweighofer et al., 2008). Our
theory of reinforcement pathology describes individuals most at risk for increased BMI as
those who are high in food reinforcement and high in impulsivity (Carr, Daniel, Lin, &
Epstein, 2011; Epstein, Salvy, Carr, Dearing, & Bickel, 2010), which has been tested in
laboratory studies (Appelhans et al., 2011; Rollins et al., 2010). Consistent with this idea,
the high-impulsivity risk alleles, 3.5R or 4R MAOA-LPR genotype show a significant
interaction with food reinforcement, such that those with high food reinforcement and the
risk allele show the highest BMIs. While this study did not measure impulsivity, future
research may consider interactions between behavioral measures of impulsivity, food
reinforcement and genotype.
MAOA-LPR and rs6314 are especially interesting polymorphisms, as both are associated
with functional changes in their respective genes. The mutation examined in rs6314 results
in charge differences in the second structure of the HTR2A receptor protein possibly
influencing protein function (Heiser et al., 2007). The A allele is a tyrosine substitution that
is related to slower calcium mobilization, which may cause a blunted response to serotonin
stimulation (Wagner, Schuhmacher, Schwab, Zobel, & Maier, 2008). MAOA is involved in
the breakdown of serotonin and dopamine and the 3.5R/4R alleles in the MAOA-LPR
mutation have been associated with increased activity (Deckert et al., 1999; Sabol et al.,
1998), which may increase the rate of neurotransmitter breakdown and decrease the amount
of dopamine and serotonin available for release and stimulation of receptors. Many previous
associations found between genes and obesity have been with non-functional SNPs that are
likely in linkage disequilibrium with a functional locus. The identification of two functional
alleles that interact with food reinforcement on BMI is an important contribution towards
elucidating potential mechanisms that influence obesity.
The polymorphisms rs2066713 and rs7997012 were found in exploratory analyses to
interact with food reinforcement and dietary hunger, and are not currently associated with
any functional gene changes. Without any functional significance, it is difficult to speculate
the mechanism by which these genes interact with food reinforcement and hunger to
influence obesity. In the case of rs2066713, the A allele only influenced BMI when food
reinforcement and hunger were low, suggesting that this gene is an obesity risk factor only
for otherwise low-risk individuals. Either increased food reinforcement or increased hunger
removed the effects of the gene. In the case of rs7997012, the gene influenced BMI when
there was a mismatch between food reinforcement and dietary hunger, such that individuals
with low hunger, but high food reinforcement and those with high hunger and low food
reinforcement, had BMI's that were influenced by increased numbers of G alleles. It is
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possible that these genes influence an individual's ability to detect hunger or satiety signals
as they are found in the serotonin system, either making them more or less sensitive to
satiety or hunger. For example, it is possible that while individuals rate their hunger as low
on the dietary questionnaire, the rs7997012 polymorphism makes them less sensitive to
satiety signals; so even with low hunger levels individuals must ingest more food to feel full.
It is interesting that all the polymorphisms that interacted with food reinforcement or hunger
to predict BMI are serotonin genes. Serotonin is hypothesized to be related to feelings of
satiety, such that increases in the neurotransmitter's availability are associated with
decreases in energy intake (Halford, Harrold, Lawton, & Blundell, 2005). Experiments with
serotonergic agonists and antagonists show that increasing serotonergic activity in the brain
can lead to decreased meal size in both animals and humans (Halford et al., 2005) and
serotonin antagonists increase energy intake, particularly of carbohydrates (Stallone &
Nicolaidis, 1989). Empirical evidence supports a role of hunger and satiety in food
reinforcement, with greater hunger predicting an increase in the reinforcing value of food
(Carr & Epstein, 2011; Raynor & Epstein, 2003). Food reinforcement is typically measured
after a preload, to measure the influence of hedonic hunger, or energy intake above normal
caloric needs (Saper, Chou, & Elmquist, 2002), rather than homeostatic hunger or the drive
to consume minimum daily energy needs (Epstein, Truesdale, Wojcik, Paluch, & Raynor,
2003; Reiss & Havercamp, 1996). The reinforcing value of food is most informative when
differences in hedonic hunger are considered, as this is the basis for excess energy intake
(Lowe & Butryn, 2007).
The combination of low food reinforcement and previously identified “risk allele” in either
MAOA-LPR or rs6314 are associated with lower BMI. While an examination of the
contributions of serotonin towards energy intake and BMI would suggest that decreased
serotonergic activity is associated with higher BMI and greater energy intake, this is not the
case for individuals low in food reinforcement. An examination of the non-risk genotype
suggests that normal or high serotonergic functioning effect on BMI is not influenced by
food reinforcement. The previous mixed results regarding the effect of serotonin on
motivation (De Vry et al., 2003; Sanders et al., 2007; Thomsen et al., 2009), may be due to
the interaction between food reinforcement and serotonin.
Food reinforcement has been identified as a potential candidate for genetic study using the
criteria outlined by Faith (Faith, 2008); including reliability (Epstein, Temple, et al., 2007),
both cross-sectional (Giesen et al., 2010; Saelens & Epstein, 1996; Temple et al., 2008) and
prospective associations with obesity (Hill et al., 2009; Temple & Epstein, 2011),
heritability (Epstein, Dearing, Temple, & Cavanaugh, 2008), and differences in at risk
individuals (Hill et al., 2009). Examining candidate genes associated with BMI and food
reinforcement did not reveal any significant associations after FDR correction. While we
were not able to identify any genes that predicted level of food reinforcement, it is still
possible that the interactions between food reinforcement and the serotonin genes are the
result of gene-gene effects that could not be identified in our sample.
Previous research from our laboratory on the relationship of food reinforcement and BMI
has focused in the dopamine receptor D2, ANKK1 or Taq1A allele (Epstein, Dearing, &
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Erbe, 2010; Epstein, Temple, et al., 2007; Epstein et al., 2004). It is interesting to note that if
the Taq1A allele had been one of a few polymorphisms examined, we would have replicated
previous results (p < 0.05), but in a more comprehensive genetic analysis correcting for
testing multiple genes, this association was not found.
This exploratory study provides a new approach to studying how gene-behavioral phenotype
interactions may predict BMI, but the study is limited due to the small sample size and
relatively large number of candidate genes. It should be noted that our variances may have
been inflated due to the Beavis effect, which describes a situation in which samples of under
500 participants tend to have larger R2 (Xu, 2003). While dopamine has been implicated in
energy intake and BMI, and responding for drug reinforcers, we examined a limited array of
dopamine polymorphisms. Due to the size of the sample, this study did not have sufficient
power to examine at gene-gene interactions as many of the genotype combinations would
not be represented, but may have been particularly interesting between genes in the
dopamine and serotonin systems.
Further research should examine the potential interaction of dopamine and serotonin
genetics and food reinforcement. The data presented in this study suggests that serotonin
may be a genetic moderator of food reinforcement, and distinguishing between serotonin's
effect on satiety and impulsivity may provide mechanisms by which serotonin influences
food reinforcement. Targeting mechanisms that influence food reinforcement and satiation
may suggest novel or individualized treatments, similar to the principles of pharmaco-
genomic therapies, perhaps by creating diets of satiating foods and limiting access to highly
reinforcing foods for at risk individuals with low serotonin and high food reinforcement.
The translation of these behavioral genetic interactions may represent a new frontier for
improving behavioral interventions.
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Effect of a mutation in RS6314 on the relationship between food reinforcement
(PMAXFOOD) and Body mass index (BMI). Effects of genotype shown for ±1 Standard
deviation of PMAXFOOD. *p-value<0.05
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Effect of a mutation in Monoamine oxidase A, MAOA-LPR on the relationship between food
reinforcement (PMAXFOOD) and Body mass index (BMI). Effects of genotype shown for ±1
Standard deviation of PMAXFOOD. MAOA-LPR is located on the X chromosome, so
analyses were stratified by sex. *p-value <0.05
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Figure 3. Results of a three way interaction between Genes, Dietary Hunger and Food
Reinforcement on BMI
A. The effect of a mutation in rs2066713 and dietary hunger (±1 Standard Deviation) on the
relationship between food reinforcement (PMAXFOOD) and Body Mass Index (BMI). The
left side illustrates the interaction between food reinforcement (±1 Standard Deviation) and
rs2066713 for low dietary hunger and the right side shows high dietary hunger. *p-value
<0.05
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B. The effect of a mutation in rs7997012 and dietary hunger (±1 Standard Deviation) on the
relationship between food reinforcement (PMAXFOOD) and Body Mass Index (BMI). The
left side illustrates the interaction between food reinforcement (±1 Standard Deviation) and
rs7997012 for low dietary hunger and the right side shows high dietary hunger. *p-value
<0.05
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